The myositis activities profile - Initial validation for assessment of polymyositis/dermatomyositis in the USA

Journal of Rheumatology

Volumn 39, Issue 11, 2012, Pages 2134-2141

  Alexanderson, Helene ^a   Reed, Ann M ^b   Ytterberg, Steven R ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAYO CLINIC   (United States)

Author keywords

Activities; Daily living; Dermatomyositis; Polymyositis; Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSTRUCT VALIDITY; CONTENT VALIDITY; DERMATOMYOSITIS; DISEASE ACTIVITY; FEMALE; FUNCTIONAL INDEX 2; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; MANUAL MUSCLE TEST; MUSCULOSKELETAL SYSTEM EXAMINATION; MYOSITIS ACTIVITIES PROFILE; POLYMYOSITIS; PRIORITY JOURNAL; QUESTIONNAIRE; TEST RETEST RELIABILITY; UNITED STATES; VISUAL ANALOG SCALE; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; POLYMYOSITIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; UNITED STATES;

EID: 84868382926     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120504     Document Type: Article

References (30)

1. Dorph C, Lundberg IE. Idiopathic inflammatory myopathies - Myositis. Best Pract Res Clin Rheumatol 2002;16:817-32.
2. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297-301.
3. Hengstman GJ, van den Hoogen FH, van Engelen BG. Treatment of the inflammatory myopathies: Update and practical recommendations. Expert Opin Pharmacother 2009;10:1183-90.
4. Alexanderson H. Exercise effects in patients with adult idiopathic inflammatory myopathies. Curr Opin Rheumatol 2009;21:158-63.
5. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: Short term and long-term outcome, and predictive factors of prognosis. J Rheumatol 2001;28:2230-7.
6. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myopathies. Rheumatology 2002;41:22-6.
7. Clarke AE, Bloch DA, Medsger TA Jr, Oddis CV. A longitudinal study of functional disability in a national cohort of patients with polymyositis/ dermatomyositis. Arthritis Rheum 1995;38:1218-24.
8. Ponyi A, Borgulya G, Constantin T, Váncsa A, Gergely L, Dankó K. Functional outcome and quality of life adult patients with idiopathic inflammatory myopathies. Rheumatology 2005;44:83-4.
9. Alemo Munters L, van Vollenhoven RF, Alexanderson H. Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis. ISRN Rheumatol 2011;2011:463124.
10. Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 2001;40:1262-73.
11. Alexanderson H, Lundberg IE, Stenström CH. Development of the myositis activities profile - Validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol 2002;29:2386-92.
12. World Health Organization. International classification of impairments, disabilities and handicaps. Beta-2 draft, full version. Geneva: World Health Organization; 1999.
13. World Health Organization. International classification of functioning, disability and health. Geneva: World Health Organization; 2001.
14. Alexanderson H, Dastmalchi M, Esbjörnsson-Liljedahl M, Opava CH, Lundberg IE. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 2007;57:768-77.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
17. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
18. Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2004;43:49-54.
19. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
20. Alexanderson H, Broman L, Tollbäck A, Josefson A, Lundberg IE, Stenström CH. Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum 2006; 55:114-22.
21. Guillemin F. Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol 1995;24:61-3.
22. Munro BH. Statistical methods for health care research. 4th ed. Philadelphia: J.B. Lippincott; 1997.
23. Nunnally J. Psychometric theory. New York: McGraw-Hill; 1978.
24. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
25. Mouthon L, Rannou F, Bérenzé A, Pagnoux C, Guilpain F, Goldwasser F, et al. Patient preference disability questionnaire in systemic sclerosis: A cross-sectional survey. Arthritis Rheum 2008;59:968-73.
26. Kuhlow H, Fransen J, Ewert T, Stucki G, Forster A, Langenegger T. Factors explaining limitations in activities and restrictions in participation in rheumatoid arthritis. Eur J Phys Rehabil Med 2010;46:169-77.
27. Verhoeven AC, Boers M, van der Linden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis. J Rheumatol 2000;27:2801-9.
28. Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W. Disease activity assessment of rheumatoid arthritis in daily practice: Validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol 2009;27:552-9.
29. Dorph C, Englund P, Nennesmo I, Lundberg IE. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Ann Rheum Dis 2006;65:1565-71.
30. Pett MA, Lackey NR, Sullivan JJ. Making sense of factor analysis: Use of factor analysis for instrument development in health care science. Thousand Oaks, CA: Sage Publications; 2003:47-9.